Perinuclear localization of internalized outer membrane vesicles carrying active cytolethal distending toxin from Aggregatibacter actinomycetemcomitans

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 31-42

  Rompikuntal, Pramod Kumar ^a   Thay, Bernard ^a   Khan, Muhammad zeb ^a   Alanko, Jonna ^a,b   Penttinen, Anna Maija ^a,b   Asikainen, Sirkka ^a,c   Wai, Sun Nyunt ^a   Oscarsson, Jan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; BACTERIAL TOXIN;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CELLULAR DISTRIBUTION; CYTOTOXICITY; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MUTANT; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; SEROTYPE; CELL CULTURE; CELL NUCLEUS; CELL SURVIVAL; CHEMISTRY; CYTOPLASM; ENDOCYTOSIS; EPITHELIUM CELL; EXOSOME; METABOLISM; PASTEURELLACEAE; PATHOGENICITY; PHYSIOLOGY;

BACTERIAL TOXINS; CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; CYTOPLASM; ENDOCYTOSIS; EPITHELIAL CELLS; EXOSOMES; FIBROBLASTS; HUMANS; PASTEURELLACEAE;

EID: 84863411717     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06069-11     Document Type: Article

References (70)

1. Ahmed HJ, et al. 2001. Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J. Med. Microbiol. 50:860-864.
2. Akifusa S, Heywood W, Nair SP, Stenbeck G, Henderson B. 2005. Mechanism of internalization of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiology 151:1395-1402.
3. Amano A, Takeuchi H, Furuta N. 2010. Outer membrane vesicles function as offensive weapons in host-parasite interactions. Microbes Infect. 12:791-798.
4. Balsalobre C, et al. 2006. Release of the type I secreted α-haemolysin via outer membrane vesicles from Escherichia coli. Mol. Microbiol. 59:99-112.
5. Bartold PM, Walsh LJ, Narayanan AS. 2000. Molecular and cell biology of the gingiva. Periodontol. 2000 24:28-55.
6. Bauman SJ, Kuehn MJ. 2009. Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells. BMC Microbiol. 9:26.
7. Belibasakis G, et al. 2002. Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. Eur. J. Oral Sci. 110:366-373.
8. Belibasakis GN, et al. 2005. The cytolethal distending toxin induces receptor activator of NF-κB ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect. Immun. 73:342-351.
9. Belibasakis GN, et al. 2005. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine 30:56-63.
10. Belibasakis GN, Mattsson A, Wang Y, Chen C, Johansson A. 2004. Cell cycle arrest of human gingival fibroblasts and periodontal ligament cells by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. APMIS 112:674-685.
11. Berlanda Scorza F, et al. 2008. Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coliΔtolR IHE3034 mutant. Mol. Cell Proteomics 7:473-485.
12. Boesze-Battaglia K, et al. 2009. Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol. J. Biol. Chem. 284:10650-10658.
13. Bomberger JM, et al. 2009. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5:e1000382.
14. Damek-Poprawa M, Haris M, Volgina A, Korostoff J, Dirienzo JM. 2011. Cytolethal distending toxin damages the oral epithelium of gingival explants. J. Dent. Res. 90:874-879.
15. Demuth DR, James D, Kowashi Y, Kato S. 2003. Interaction of Actinobacillus actinomycetemcomitans outer membrane vesicles with HL60 cells does not require leukotoxin. Cell. Microbiol. 5:111-121.
16. Ellis TN, Kuehn MJ. 2010. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 74:81-94.
17. Elwell C, Chao K, Patel K, Dreyfus L. 2001. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect. Immun. 69:3418-3422.
18. Elwell CA, Dreyfus LA. 2000. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 37:952-963.
19. Fabris AS, DiRienzo JM, Wikstrom M, Mayer MP. 2002. Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations. Oral Microbiol. Immunol. 17:231-238.
20. Fujiwara T, Oda K, Yokota S, Takatsuki A, Ikehara Y. 1988. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 263:18545-18552.
21. Furuta N, et al. 2009. Porphyromonas gingivalis outer membrane vesicles enter human epithelial cells via an endocytic pathway and are sorted to lysosomal compartments. Infect. Immun. 77:4187-4196.
22. Goulhen F, et al. 1998. Subcellular localization and cytotoxic activity of the GroEL-like protein isolated from Actinobacillus actinomycetemcomitans. Infect. Immun. 66:5307-5313.
23. Guerra L, Cortes-Bratti X, Guidi R, Frisan T. 2011. The biology of the cytolethal distending toxins. Toxins 3:172-190.
24. Guerra L, et al. 2009. A novel mode of translocation for cytolethal distending toxin. Biochim. Biophys. Acta 1793:489-495.
25. Haghjoo E, Galan JE. 2004. Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterialinternalization pathway. Proc. Natl. Acad. Sci. U. S. A. 101:4614-4619.
26. Harder T, Scheiffele P, Verkade P, Simons K. 1998. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141:929-942.
27. Henning U, Schwarz H, Chen R. 1979. Radioimmunological screening method for specific membrane proteins. Anal. Biochem. 97:153-157.
28. Hoekstra D, de Boer T, Klappe K, Wilschut J. 1984. Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23:5675-5681.
29. Horstman AL, Kuehn MJ. 2000. Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J. Biol. Chem. 275:12489-12496.
30. Johansson A, Sandström G, Claesson R, Hänström L, Kalfas S. 2000. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity. Eur. J. Oral Sci. 108:136-146.
31. Karched M, et al. 2008. Vesicle-independent extracellular release of a proinflammatory outer membrane lipoprotein in free-soluble form.BMC Microbiol. 8:18.
32. Kato S, Kowashi Y, Demuth DR. 2002. Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb. Pathog. 32:1-13.
33. Kebschull M, Demmer RT, Papapanou PN. 2010. "Gum bug, leave my heart alone!"-epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res. 89:879-902.
34. Kelk P, Claesson R, Chen C, Sjöstedt A, Johansson A. 2008. IL-1β secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. Int. J. Med. Microbiol. 298:529-541.
35. Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ. 2004. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 23:4538-4549.
36. Kouokam JC, et al. 2006. Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infect. Immun. 74:2022-2030.
37. Kulp A, Kuehn MJ. 2010. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 64:163-184.
38. Lally ET, et al. 1989. Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins. J. Biol. Chem. 264:15451-15456.
39. Lally ET, et al. 1997. RTX toxins recognize a β2 integrin on the surface of human target cells. J. Biol. Chem. 272:30463-30469.
40. Lara-Tejero M, Galan JE. 2000. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290:354-357.
41. Lara-Tejero M, Galan JE. 2001. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect. Immun. 69:4358-4365.
42. Lara-Tejero M, Galan JE. 2002. Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol. 10:147-152.
43. Lee RB, Hassane DC, Cottle DL, Pickett CL. 2003. Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells. Infect. Immun. 71:4883-4890.
44. Lindmark B, et al. 2009. Outer membrane vesicle-mediated release of cytolethal distending toxin (CDT) from Campylobacter jejuni. BMC Microbiol. 9:220.
45. Lippincott-Schwartz J, et al. 1990. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60:821-836.
46. McSweeney LA, Dreyfus LA. 2004. Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell. Microbiol. 6:447-458.
47. Nalbant A, Chen C, Wang Y, Zadeh HH. 2003. Induction of T-cell apoptosis by Actinobacillus actinomycetemcomitans mutants with deletion of ltxA and cdtABC genes: possible activity of GroEL-like molecule. Oral Microbiol. Immunol. 18:339-349.
48. Nesic D, Hsu Y, Stebbins CE. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433.
49. Nishikubo S, et al. 2003. An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J. Biol. Chem. 278:50671-50681.
50. Ohara M, Miyauchi M, Tsuruda K, Takata T, Sugai M. 2011. Topical application of Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces cell cycle arrest in the rat gingival epithelium in vivo. J. Periodontal Res. 46:389-395.
51. Ohara M, Oswald E, Sugai M. 2004. Cytolethal distending toxin: a bacterial bullet targeted to nucleus. J. Biochem. 136:409-413.
52. Olofsson A, et al. 2010. Biochemical and functional characterization of Helicobacter pylori vesicles. Mol. Microbiol. 77:1539-1555.
53. Orlandi PA, Fishman PH. 1998. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolaelike domains. J. Cell Biol. 141:905-915.
54. Oscarsson J, Karched M, Thay B, Chen C, Asikainen S. 2008. Proinflammatory effect in whole blood by free-soluble bacterial components released from planktonic and biofilm cells. BMC Microbiol. 8:206.
55. Paju S, et al. 2000. Localization of heat shock proteins in clinical Actinobacillus actinomycetemcomitans strains and their effects on epithelial cell proliferation. FEMS Microbiol. Lett. 182:231-235.
56. Paul-Satyaseela M, et al. 2006. Immunoproteomics of Actinobacillus actinomycetemcomitans outer-membrane proteins reveal a highly immunoreactive peptidoglycan-associated lipoprotein. J. Med. Microbiol. 55:931-942.
57. Saarela M, et al. 1992. Frequency and stability of mono-or poly-infection by Actinobacillus actinomycetemcomitans serotypes a, b, c, d or e. Oral Microbiol. Immunol. 7:277-279.
58. Shenker BJ, et al. 1999. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J. Immunol. 162:4773-4780.
59. Simpson DL, Berthold P, Taichman NS. 1988. Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin. Infect. Immun. 56:1162-1166.
60. Slots J, Genco RJ. 1984. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J. Dent. Res. 63:412-421.
61. Smith JL, Bayles DO. 2006. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit. Rev. Microbiol. 32:227-248.
62. Socransky SS, Haffajee AD. 1992. The bacterial etiology of destructive periodontal disease: current concepts. J. Periodontol. 63:322-331.
63. Sugai M, et al. 1998. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 66:5008-5019.
64. Tan KS, Song KP, Ong G. 2002. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease. J. Periodontal Res. 37:268-272.
65. Ueno Y, et al. 2006. Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin. Infect. Immun. 74:3480-3487.
66. van Winkelhoff AJ, Slots J. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 20:122-135.
67. Wai SN, et al. 2003. Vesicle-mediated export and assembly of poreforming oligomers of the enterobacterial ClyA cytotoxin. Cell 115:25-35.
68. Wang Y, Goodman SD, Redfield RJ, Chen C. 2002. Natural transformation and DNA uptake signal sequences in Actinobacillus actinomycetemcomitans. J. Bacteriol. 184:3442-3449.
69. Wising C, et al. 2002. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model. Microb. Pathog. 33:49-62.
70. Yamano R, et al. 2003. Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J. Clin. Microbiol. 41:1391-1398.